Previous studies have illustrated that CAV-1 may be involved at the earlies stages of atherosclerosis development through increased LDL particle transcytosis, endothelial cells activation, and induced protherogenic molecule CD36 and vascular cell adhesion molecule-1 expression [12,38–39]. Here, VCAM1 is linked to atherosclerosis.